title: Epirubicin, cisplatin and intermittent continuous infusion of 5-fluorouracil in advanced gastric cancer: an effective regimen?
authors.forename: R L
authors.initials: RL
authors.lastname: Poorter
authors.forename: P J
authors.initials: PJ
authors.lastname: Bakker
authors.forename: C W
authors.initials: CW
authors.lastname: Taat
authors.forename: J F
authors.initials: JF
authors.lastname: Bartelsman
authors.forename: C H
authors.initials: CH
authors.lastname: Veenhof
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D015251:Epirubicin; D002945:Cisplatin; D005472:Fluorouracil